Chapter 11. Gastrointestinal Disorders

Authors

Synopsis

Author

Mr. Gogannamatam Lalitha Sagar

PharmD Intern, Department of Pharmacy Practice, Koringa College of Pharmacy, Korangi, Andhra Pradesh, India

Abstract

Pharmacological approaches to gastrointestinal disorders integrate pathophysiological mechanisms with symptom severity and disease complications. Acid-related disorder management utilizes acid suppression strategies, mucosal protective agents, and Helicobacter pylori eradication protocols based on specific diagnoses. Inflammatory bowel disease treatment incorporates anti-inflammatory agents, immunomodulators, and biological therapies with systematic monitoring of disease activity and complications. Functional gastrointestinal disorder management focuses on predominant symptom patterns utilizing neuromodulators, motility agents, and targeted symptom-based interventions. Hepatic condition treatment requires careful medication selection and dosing based on liver function parameters, with specific protocols for viral hepatitis, cirrhosis, and metabolic liver disease. Nutritional support strategies incorporate enteral and parenteral interventions based on nutritional assessment parameters and specific disease requirements. Treatment selection integrates factors including disease severity, comorbidities, and hepatic metabolism considerations.

Keywords: Gastrointestinal pharmacotherapy, Acid suppression, Inflammatory bowel disease, Hepatic disorders, Nutritional support

VIEW PDF

Published

17 February 2025

How to Cite

Chapter 11. Gastrointestinal Disorders. (2025). In Evidence-Based Pharmacotherapy in Clinical Practice (pp. 490-557). ThinkPlus Pharma Publications. https://doi.org/10.69613/dbzadt64